Practical properties of some structural mean analyses of the effect of compliance in randomized trials

Controlled Clinical Trials

Volumn 20, Issue 6, 1999, Pages 531-546

  Fischer Lapp, Krista ^a   Goetghebeur, Els ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Causal inference; Estimating equations; Noncompliance; Placebo controlled clinical trial; Structural nested mean models

Indexed keywords

DRUG; PLACEBO;

ACCURACY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESEARCH; DRUG RESPONSE; HUMAN; MODEL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVIEW;

EID: 0033452904     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(99)00027-6     Document Type: Article

References (15)

1. Gilbert J.P., Meier P., Runke C.L.et al. Report of the committee for the assessments of biometric aspects of controlled clinical trials of hypoglycemic agents. JAMA. 231:1975;583-608.
2. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 303:1980;1038-1041.
3. Goetghebeur E., Pocock S. Statistical issues in allowing for non-compliance and withdrawal. Drug Information J. 27:1993;837-845.
4. Mark S.D., Robins J.M. A method for the analysis of randomized trials with compliance information. an application to the multiple risk factor intervention trial Control Clin Trials. 14:1993;79-97.
5. Angrist J.D., Imbens G.W., Rubin D.B. Identification of causal effects using instrumental variables, with rejoinder. J Am Stat Assoc. 91:1996;444-471.
6. Efron B., Feldman D. Compliance as an explanatory variable in clinical trials. J Am Stat Assoc. 86(withrejoinder,):1991;9-25.
7. Albert J.M., DeMets D.L. On a model-based approach to estimating efficacy in clinical trials. Stat Med. 13:1994;2323-2335.
8. Sommer A., Zeger S.L. On estimating efficacy from clinical trials. Stat Med. 10:1991;45-52.
9. Cuzick J., Edwards R., Segnan N. Adjusting for non-compliance and contamination in randomised clinical trials. Stat Med. 16:1997;1017-1029.
10. Goetghebeur E., Molenberghs G. Causal inference in placebo-controlled clinical trials with binary outcome and ordered compliance. J Am Stat Assoc. 91:1996;928-934.
11. Robins J.M., Tsiatis A.A. Correcting for non-compliance in randomized clinical trials using rank preserving structural failure time models. Comm Stat Theory Methods. 20:1991;2609-2631.
12. Robins J.M. Correcting for non-compliance in randomized trials using structural nested mean models. Comm Stat Theory Methods. 23:1994;2379-2412.
13. Goetghebeur E., Lapp K. The effect of treatment compliance in a placebo-controlled trial. regression with unpaired data Applied Stat. 46:1997;351-364.
14. Newey W.K. Semiparametric efficiency bounds. J Applied Econometrics. 5:1990;99-135.
15. Patient compliance and therapeutic coverage. comparison of amlodipine and slow release nifedipine in the treatment of hypertension Eur J Clin Pharmacol. 47:1995;477-481.